News

  • Kyowa Hakko U.S.A. Focuses on Cognizin™ Research at SupplySide East

    May 14, 2004

    View news »
  • Kyowa Hakko Sponsors VendorWorks Seminar at SupplySide East Focusing On Cognizin™ Research

    April 28, 2004 NutrAward winner for best new product to be featured at SupplySide East New York, N.Y. – Kyowa Hakko, one of the world leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products, and recipient of the 2004 Nutracon NutrAward, for the best new ingredient of 2003 for Cognizin™, will sponsor a VendorWorks seminar featuring the health benefits of Cognizin™ brand citicoline at SupplySide East at the Baltimore Convention Center on Friday, May 7 from 11:00 to 11:50 a.m in Room 344. The seminar keynote speaker is Dr. Alexander G. Sc...

    View news »
  • Kyowa Hakko Wins NutrAward For Cognizin™

    March 6, 2004 Cognizin™ voted best new ingredient by Nutracon attendees New York, N.Y. – Kyowa Hakko, one of the world leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products, was awarded the 2003 NutrAward for the best new innovative ingredient of the year at Nutracon, the premier scientific education and networking conference, on March 6. Cognizin™ citicoline was voted number one by the attendees of Nutracon 2004 in Anaheim, CA, at the Anaheim Convention Center. Voting was based on scientific merit, efficacy, safety, innovation, mar...

    View news »
  • CSPHP From Kyowa Hakko Kogyo Receives GRAS Approval

    March 6, 2004 CSPHP soy protein/phospholipid complex system may help maintain healthy cholesterol levels New York, N.Y. – Kyowa Hakko Kogyo, and its US subsidiary, Kyowa Hakko U.S.A., have announced the Food and Drug Administration (FDA) considers CSPHP, a soy protein/phospholipid complex system that may help maintain healthy cholesterol levels within the normal range, as Generally Recognized As Safe (GRAS). CSPHP, an abbreviation for C-fraction soy protein hydrolysate with bound phospholipids, is a newly developed soy peptide. A recent study by Kyowa Hakko Kogyo at Gifu University and ...

    View news »
  • Kyowa Hakko Presents Cognizin™ and CSPHP at Nutracon Poster Session

    March 1, 2004 New York, N.Y. – Kyowa Hakko U.S.A. and Kyowa Hakko Kogyo, a subsidiary of Kyowa Hakko U.S.A., will each present a poster session at Nutracon, the premier scientific education and networking conference in Anahiem, CA, March 4-5. The Kyowa Hakko U.S.A. poster session features Cognizin™ brand citicoline and a study using a Morris water maze cylindrical water-filled pool with a hidden platform to research the memory capacity of mice. The study involving 40 eight week-old male mice focused on the tendency of mice to memorize the platform location and to mount it from the water. ...

    View news »
  • Kyowa Hakko U.S.A. Launches Cognizin™ Branding Campaign

    February 16, 2004 Cognizin™ is first branded ingredient for international health ingredients manufacturer New York, N.Y. – Kyowa Hakko U.S.A., Inc. has launched a branded ingredient campaign for its novel and powerful anti-aging citicoline ingredient under the name of Cognizin™. The company has completed a product logo which will be available for all product manufacturers using the ingredient in their formulations, plus a product tag line, “For the Evolution of Your Mind™.” A Cognizin™ web site and two trade print ads will also be part of the program. Kyowa Hakko is one of the world lead...

    View news »
  • Kyowa Hakko U.S.A. Introduces Cognizin™ For Brain Health

    October 7, 2003 Cognizin™ becomes first branded ingredient for international health ingredients manufacturer New York, N.Y. – Kyowa Hakko U.S.A., Inc. announced at SupplySide West in Las Vegas it has trademarked its novel and powerful anti-aging Citicoline ingredient under the brand name of Cognizin™. Citicoline has been used in the treatment of neurodegenerative disorders associated with stroke, cerebrovascular pathology, brain aging and head trauma. Scientific studies have indicated effectiveness in treating Alzheimer’s and Parkinson’s disease and improved stroke recuperation, as well as...

    View news »
  • Kyowa Hakko U.S.A. Sponsors Citicoline Seminar and Lunch at SupplySide West in Las Vegas on October 2

    August 12, 2003 New York, N.Y. – Kyowa Hakko U.S.A., one of the world leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products, will sponsor a seminar featuring the Recently Discovered Health Benefits of Citicoline at SupplySide West in Las Vegas, Thursday, October 2 from Noon until 1 p.m. at the Venetian Hotel/Sands Expo, room 803-804. Keynote speaker is Dr. Alexander G. Schauss, PhD, director, Natural and Medicinal Products Research, Life Sciences Division, American Institute for Biosocial and Medical Research Inc., and leading scientific ...

    View news »
  • Kyowa Hakko Kogyo Offers Innovative Diacid for High Performance Coatings Applications

    March 1, 2002 Tokyo, Japan - Kyowa Hakko Kogyo Co. Ltd. announced the commercial availability of a new high performance diacid, 2, 4-Diethylglutaric Acid. Ideal for demanding coatings applications, 2, 4-Diethylglutaric Acid provides high solubility for solvents and resins when compared to conventional straight chain diacids. As a cross-linker for acrylic epoxy resin-based powder coatings, the new product's higher cross-linking density promotes exceptional surface gloss, acid and mar resistance.

    View news »
  • Kyowa Hakko USA Addresses FDA TSE/BSE Committee Meeting on Amino Acid Production Method Safety

    January 2, 2002 New York, N.Y. - A recent meeting of the U.S. Food and Drug Administration's Transmissible Spongiform Encephalopathies (TSE) Advisory Committee brought together several industry leaders to discuss amino acid production and the associated theoretical risk of contamination from their use in the production of biological products. One of the world's largest producers of amino acids, Kyowa Hakko submitted detailed information on its fermentation techniques for the production of amino acids. The process, pioneered by Kyowa Hakko nearly half a century ago, utilizes no animal-deri...

    View news »